One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

Francesco Burzotta, Carlo Trani, Filippo Crea, Giovanni Paolo Talarico, Antonella Tommasino, Giampaolo Niccoli, Italo Porto, Antonio Maria Leone, Rocco Mongiardo, Giovanni Schiavoni

Risultato della ricerca: Contributo in rivistaArticolo in rivista

7 Citazioni (Scopus)

Abstract

Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.
Lingua originaleEnglish
pagine (da-a)268-273
Numero di pagine6
RivistaCatheterization and Cardiovascular Interventions
Volume81
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • percutaneus coronary interventions
  • zotarolimus eluting-stents

Fingerprint

Entra nei temi di ricerca di 'One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology'. Insieme formano una fingerprint unica.

Cita questo